Gender Differences in Leukemia Outcomes Based on Health Care Expenditures Using Estimates from the GLOBOCAN 2020

Overview

Journal Arch Public Health

Publisher Biomed Central

Date 2023 Aug 22

PMID 37605241

Authors

Maedeh Amini

Rajesh Sharma

Chinmay Jani

Affiliations

Soon will be listed here.

Abstract

Background: Leukemia contributes significantly to the global cancer burden. Due to the importance of evaluating improvements in leukemia outcomes, the current study aimed to examine the variations in mortality-to-incidence ratio (MIR) between genders and association of MIR with the health expenditures in selected countries.

Methods: The leukemia incidence and mortality rates were extracted from the GLOBOCAN 2020 database. In total, 56 countries were included based on the data quality reports and the exclusion of missing data. The associations of MIR and changes in MIR over time ([Formula: see text]MIR) with the human development index (HDI), current health expenditure (CHE) per capita, and current health expenditure as a percentage of gross domestic product (CHE/GDP) were investigated using Spearman's rank correlation coefficient.

Results: In 2020, an estimated 474,519 new cases of leukemia were diagnosed globally, and 311,594 deaths occurred due to the disease. Male patients exhibited a higher incidence and mortality of leukemia compared to females on a global scale. Our analysis revealed that the MIRs were the highest and lowest in Egypt (0.79) and the United States (0.29), respectively. Remarkably, countries with greater HDI, higher CHE per capita, and a higher CHE/GDP tended to have lower MIR in both genders and within gender-specific subgroups. The δMIR demonstrated a significant negative correlation with HDI and CHE per capita, whereas no significant associations were observed among female patients for CHE/GDP. Besides, all three indicators showed trends towards negative correlations with δMIR among males, though these trends were not statistically significant (p>0.05).

Conclusions: Generally, leukemia MIRs tended to be most favorable (i.e., lower) in countries with high HDI and high health expenditure. The gender differences observed in leukemia outcomes may reflect the potential influence of social, material, behavioral, and biological factors.

Citing Articles

Association between TLR 2 (rs3804099), TLR4 (rs4986790), and TLR 9 (rs187084) polymorphism and leukemia risk: a systematic review and meta-analysis.

Kumar R, Dutta A, Phukan M Immunol Res. 2025; 73(1):35.

PMID: 39815014 DOI: 10.1007/s12026-025-09592-y.

Elucidating the Role of Estrogen Effects in Leukemia: Insights from Single-Cell RNA Sequencing and Mendelian Randomization.

Zhao J, Yu Y, Liu C, Liu R, Sun M, Zhuang J J Cancer. 2025; 16(3):888-897.

PMID: 39781360 PMC: 11705057. DOI: 10.7150/jca.100610.

'Between Inner Strength and Fighting Prejudice': Psycho-Social Processes Implemented by Women with Leukemia Along the Illness Trajectory: A Grounded Theory Study.

Artioli G, Taffurelli C, Cervantes Camacho V, Botti S, Lupo R, Conte L Curr Oncol. 2024; 31(10):6272-6288.

PMID: 39451772 PMC: 11506378. DOI: 10.3390/curroncol31100468.

Population-based overall and net survival of childhood leukemia at 1-, 5-, and 10-years of follow-up in three regions of Colombia.

Godoy-Casasbuenas N, Gil F, Arias N, Perez C, Cruz H, Goyes L Ecancermedicalscience. 2024; 18:1759.

PMID: 39430074 PMC: 11489091. DOI: 10.3332/ecancer.2024.1759.

Sex-dependent niche responses modulate steady-state and regenerative hematopoiesis.

Chaudhary R, Smith J, Tiwari R, Klein B, Cordova B, Petroze F Exp Hematol. 2024; 137:104247.

PMID: 38848877 PMC: 11810041. DOI: 10.1016/j.exphem.2024.104247.

References

Orsi L, Rudant J, Ajrouche R, Leverger G, Baruchel A, Nelken B . Parental smoking, maternal alcohol, coffee and tea consumption during pregnancy, and childhood acute leukemia: the ESTELLE study. Cancer Causes Control. 2015; 26(7):1003-17. DOI: 10.1007/s10552-015-0593-5. View

Luo X, Ke Z, Guan X, Zhang Y, Huang L, Zhu J . The comparison of outcome and cost of three protocols for childhood non-high risk acute lymphoblastic leukemia in China. Pediatr Blood Cancer. 2008; 51(2):204-9. DOI: 10.1002/pbc.21598. View

Gopal S, Wood W, Lee S, Shea T, Naresh K, Kazembe P . Meeting the challenge of hematologic malignancies in sub-Saharan Africa. Blood. 2012; 119(22):5078-87. PMC: 4507039. DOI: 10.1182/blood-2012-02-387092. View

Yang X, Chen H, Man J, Zhang T, Yin X, He Q . Secular trends in the incidence and survival of all leukemia types in the United States from 1975 to 2017. J Cancer. 2021; 12(8):2326-2335. PMC: 7974881. DOI: 10.7150/jca.52186. View

Choi E, Lee S, Nhung B, Suh M, Park B, Jun J . Cancer mortality-to-incidence ratio as an indicator of cancer management outcomes in Organization for Economic Cooperation and Development countries. Epidemiol Health. 2017; 39:e2017006. PMC: 5434228. DOI: 10.4178/epih.e2017006. View

Liu Y, Chen J, Tang J, Ni S, Xue H, Pan C . Cost of childhood acute lymphoblastic leukemia care in Shanghai, China. Pediatr Blood Cancer. 2009; 53(4):557-62. DOI: 10.1002/pbc.22127. View

Ben Lakhal R, Ghedira H, Bellaaj H, Ben Youssef Y, Menif S, Manai Z . Chronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience). Ann Hematol. 2018; 97(4):597-604. DOI: 10.1007/s00277-017-3224-2. View

Sung W, Wang S, Hsieh T, Ho C, Huang C, Kao Y . Favorable mortality-to-incidence ratios of kidney Cancer are associated with advanced health care systems. BMC Cancer. 2018; 18(1):792. PMC: 6091202. DOI: 10.1186/s12885-018-4698-6. View

Gu L, Li J, Xue H, Tang J, Zhao H, Ye H . Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China. Leuk Lymphoma. 2008; 49(3):488-94. DOI: 10.1080/10428190701784730. View

10.

Abaerei A, Ncayiyana J, Levin J . Health-care utilization and associated factors in Gauteng province, South Africa. Glob Health Action. 2017; 10(1):1305765. PMC: 5496078. DOI: 10.1080/16549716.2017.1305765. View

11.

Mostert S, Arora R, Arreola M, Bagai P, Friedrich P, Gupta S . Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group. Lancet Oncol. 2011; 12(8):719-20. DOI: 10.1016/S1470-2045(11)70128-0. View

12.

Dorak M, Karpuzoglu E . Gender differences in cancer susceptibility: an inadequately addressed issue. Front Genet. 2012; 3:268. PMC: 3508426. DOI: 10.3389/fgene.2012.00268. View

13.

Sissolak G, Badenhorst J, Steenkamp J, Heaney M, Louw V, Schnugh D . Treatment Outcomes in CML Patients Treated With Tyrosine Kinase Inhibitors at a Tertiary Teaching Hospital in South Africa. Clin Lymphoma Myeloma Leuk. 2015; 15(12):803-10. DOI: 10.1016/j.clml.2015.09.006. View

14.

Mazzarella L, Botteri E, Matthews A, Gatti E, Di Salvatore D, Bagnardi V . Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolism. Haematologica. 2019; 105(6):1559-1566. PMC: 7271575. DOI: 10.3324/haematol.2019.223925. View

15.

Vostakolaei F, Karim-Kos H, Janssen-Heijnen M, Visser O, Verbeek A, Kiemeney L . The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. Eur J Public Health. 2010; 21(5):573-7. DOI: 10.1093/eurpub/ckq120. View

16.

Friedrich P, Lam C, Kaur G, Itriago E, Ribeiro R, Arora R . Determinants of Treatment Abandonment in Childhood Cancer: Results from a Global Survey. PLoS One. 2016; 11(10):e0163090. PMC: 5063311. DOI: 10.1371/journal.pone.0163090. View

17.

Garcia-Gonzalez P, Boultbee P, Epstein D . Novel Humanitarian Aid Program: The Glivec International Patient Assistance Program-Lessons Learned From Providing Access to Breakthrough Targeted Oncology Treatment in Low- and Middle-Income Countries. J Glob Oncol. 2017; 1(1):37-45. PMC: 5551649. DOI: 10.1200/JGO.2015.000570. View

18.

Hao T, Li-Talley M, Buck A, Chen W . An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States. Sci Rep. 2019; 9(1):12070. PMC: 6700310. DOI: 10.1038/s41598-019-48445-1. View

19.

Ribeiro R, Pui C . Treatment of acute lymphoblastic leukemia in low- and middle-income countries: challenges and opportunities. Leuk Lymphoma. 2008; 49(3):373-6. DOI: 10.1080/10428190701882179. View

20.

Li B, Tang H, Cheng Z, Zhang Y, Xiang H . The Current Situation and Future Trend of Leukemia Mortality by Sex and Area in China. Front Public Health. 2020; 8:598215. PMC: 7759534. DOI: 10.3389/fpubh.2020.598215. View